semaglutide monthly injection GLP-1 Weight Loss Options Semaglutide Services Vancouver Washington for

Price, J.W

Gastrointestinal side effects include: Nausea (15-30% of patients depending on dose): Usually mild to moderate and decreasing over time Diarrhea (13-24%): May contribute to dehydration if persistent Vomiting (6-12%): More common at higher doses Constipation (5-17%): Can alternate with diarrhea in some patients Abdominal pain (6-10%): Typically mild and self-limiting Decreased appetite : An intended effect contributing to weight loss Hypoglycemia risk varies depending on concurrent medications

It represents a midway point in the development of semaglutide, gaining approval in 2014 for the same purposes as liraglutide and eventually being replaced by semaglutide

In high-fat-fed rats, [dA(2)]GLP-1/GcG reduced body weight nonfasting plasma glucose, and boosted circulating plasma insulin concentrations when given twice daily for 21 days

ISSN 0009-9236

Itoh, Z